ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Cardiovascular Endocrinology
This article is part of the Research TopicInsights into the Molecular and Cellular Mechanisms of Insulin ResistanceView all 3 articles
Insulin resistance and its association with coronary heart disease : insights from bioinformatics analysis
Provisionally accepted- 1Fujian Medical University, Fuzhou, China
- 2The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Evidence on the relationship between no-insulin-based insulin resistance (IR) surrogates and the prevalence of coronary heart disease (CHD) in remains limited. Here, we assess the associations between multiple non–insulin-based IR surrogates and CHD, delineating subgroups at heightened susceptibility across demographic and cardiometabolic strata. We further explore plausible mechanistic pathways and perform mediation analyses to elucidate the pathophysiological links between IR and CHD. Methods: This study analyzed 7,419 participants from Fujian Medical University hospitals (2018–2024). Multivariate logistic regression and restricted cubic splines (RCS) were performed to evaluate the relationship between the atherogenic index of plasma (AIP index), triglyceride glucose index (TyG index), the metabolic score for insulin resistance (METS-IR), and triglyceride(TG) /high density lipoprotein cholesterol(HDL-C) ratio (TG/ HDL-C ratio) and the prevalence of CHD. Subgroup analysis and interaction analysis were employed to identify effect modifiers associated with the IR-CHD relationship, whilst bioinformatics analysis and mediation analysis were utilised to identify and quantify potential mediating effects within this association. Results :In primary analyses, surrogate markers of IR were positively associated with the prevalence of CHD, with odd ratios ranging between 1.039 and 1.612. Moreover, physical inactivity was the predominant effect modifier (interaction P-value < 0.05), with a possible additional influence of younger age, so that sedentary adults <60 years with elevated IR surrogates appeared particularly vulnerable. Mechanistically, bioinformatic enrichment analyses highlighted three core pathways, including AGE–RAGE signaling in diabetic complications, FoxO signaling, and adipocytokine signaling, providing context for the observed patterns. Finally, mediation analyses indicated that fasting plasma glucose mediated 8.15%–55.33% of the associations, including AIP index, TyG index, METS-IR, and ln(TG/HDL-C). Conclusion:In this large hospital-based cross-sectional sample, non–insulin-based IR surrogates were positively associated with the prevalence of CHD and may help identify groups with a higher likelihood of having CHD. Glycemic pathways and physical inactivity emerged as important correlates of these associations and deserve further evaluation in longitudinal studies.
Keywords: coronary heart disease, Insulin Resistance, Fasting plasma glucose, bioinformatic enrichment analyses, Mediating effect
Received: 23 Oct 2025; Accepted: 25 Nov 2025.
Copyright: © 2025 Lu, Liu, Song, Lin, Zhou, Zeng, Li, Li, Xie, Lin and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Siying Wu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
